APO Research
Talk to an analyst

APO RESEARCH · REPORT

E2 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global E2 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchE2 Antibody Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal E2 Antibody Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal E2 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E2 Antibody Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal E2 Antibody Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global E2 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of E2 Antibody include Thermo Fisher Scientific, Merck, United States Biological, Boster Biological Technology, Sino Biological, Santa Cruz Biotechnology, Proteintech, Miltenyi Biotec and LSBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global E2 Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of E2 Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents E2 Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the E2 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

E2 Antibody Segment by Company

Thermo Fisher Scientific

Merck

United States Biological

Boster Biological Technology

Sino Biological

Santa Cruz Biotechnology

Proteintech

Miltenyi Biotec

LSBio

ImmuQuest

HUABIO

G Biosciences

FineTest

Creative Diagnostics

Creative Biolabs

Bethyl

Aviva Systems Biology

Abnova

Abcam

E2 Antibody Segment by Type

Polyclonal

Monoclonal

E2 Antibody Segment by Application

Western Blot

Enzyme Linked Immunosorbent Assay

Immunofluorescence

Others

E2 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E2 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the E2 Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of E2 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of E2 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of E2 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. E2 Antibody Industry Trends Table 2. E2 Antibody Industry Drivers Table 3. E2 Antibody Industry Opportunities and Challenges Table 4. E2 Antibody Industry Restraints Table 5. Global E2 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global E2 Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global E2 Antibody Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global E2 Antibody Sales Market Share by Manufacturers Table 9. Global E2 Antibody Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global E2 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global E2 Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global E2 Antibody Manufacturers, Product Type & Application Table 13. Global E2 Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global E2 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polyclonal Table 17. Major Manufacturers of Monoclonal Table 18. Global E2 Antibody Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global E2 Antibody Sales by Type (2021-2026) & (Kg) Table 20. Global E2 Antibody Sales by Type (2027-2032) & (Kg) Table 21. Global E2 Antibody Sales Market Share by Type (2021-2026) Table 22. Global E2 Antibody Sales Market Share by Type (2027-2032) Table 23. Global E2 Antibody Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global E2 Antibody Revenue by Type (2021-2026) & (Kg) Table 25. Global E2 Antibody Revenue by Type (2027-2032) & (Kg) Table 26. Global E2 Antibody Revenue Market Share by Type (2021-2026) Table 27. Global E2 Antibody Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Western Blot Table 29. Major Manufacturers of Enzyme Linked Immunosorbent Assay Table 30. Major Manufacturers of Immunofluorescence Table 31. Major Manufacturers of Others Table 32. Global E2 Antibody Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global E2 Antibody Sales by Application (2021-2026) & (Kg) Table 34. Global E2 Antibody Sales by Application (2027-2032) & (Kg) Table 35. Global E2 Antibody Sales Market Share by Application (2021-2026) Table 36. Global E2 Antibody Sales Market Share by Application (2027-2032) Table 37. Global E2 Antibody Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global E2 Antibody Revenue by Application (2021-2026) & (Kg) Table 39. Global E2 Antibody Revenue by Application (2027-2032) & (Kg) Table 40. Global E2 Antibody Revenue Market Share by Application (2021-2026) Table 41. Global E2 Antibody Revenue Market Share by Application (2027-2032) Table 42. Global E2 Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global E2 Antibody Sales by Region (2021-2026) & (Kg) Table 44. Global E2 Antibody Sales Market Share by Region (2021-2026) Table 45. Global E2 Antibody Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global E2 Antibody Sales Forecasted Market Share by Region (2027-2032) Table 47. North America E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America E2 Antibody Sales by Country (2021-2026) & (Kg) Table 49. North America E2 Antibody Sales by Country (2027-2032) & (Kg) Table 50. Europe E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe E2 Antibody Sales by Country (2021-2026) & (Kg) Table 52. Europe E2 Antibody Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific E2 Antibody Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific E2 Antibody Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa E2 Antibody Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa E2 Antibody Sales by Country (2027-2032) & (Kg) Table 59. Global E2 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global E2 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 61. Global E2 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 62. Global E2 Antibody Revenue Market Share by Region (2021-2026) Table 63. Global E2 Antibody Revenue Market Share by Region (2027-2032) Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific E2 Antibody Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck E2 Antibody Product Portfolio Table 73. Merck Recent Development Table 74. United States Biological Company Information Table 75. United States Biological Business Overview Table 76. United States Biological E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. United States Biological E2 Antibody Product Portfolio Table 78. United States Biological Recent Development Table 79. Boster Biological Technology Company Information Table 80. Boster Biological Technology Business Overview Table 81. Boster Biological Technology E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Boster Biological Technology E2 Antibody Product Portfolio Table 83. Boster Biological Technology Recent Development Table 84. Sino Biological Company Information Table 85. Sino Biological Business Overview Table 86. Sino Biological E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sino Biological E2 Antibody Product Portfolio Table 88. Sino Biological Recent Development Table 89. Santa Cruz Biotechnology Company Information Table 90. Santa Cruz Biotechnology Business Overview Table 91. Santa Cruz Biotechnology E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Santa Cruz Biotechnology E2 Antibody Product Portfolio Table 93. Santa Cruz Biotechnology Recent Development Table 94. Proteintech Company Information Table 95. Proteintech Business Overview Table 96. Proteintech E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Proteintech E2 Antibody Product Portfolio Table 98. Proteintech Recent Development Table 99. Miltenyi Biotec Company Information Table 100. Miltenyi Biotec Business Overview Table 101. Miltenyi Biotec E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Miltenyi Biotec E2 Antibody Product Portfolio Table 103. Miltenyi Biotec Recent Development Table 104. LSBio Company Information Table 105. LSBio Business Overview Table 106. LSBio E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. LSBio E2 Antibody Product Portfolio Table 108. LSBio Recent Development Table 109. ImmuQuest Company Information Table 110. ImmuQuest Business Overview Table 111. ImmuQuest E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. ImmuQuest E2 Antibody Product Portfolio Table 113. ImmuQuest Recent Development Table 114. HUABIO Company Information Table 115. HUABIO Business Overview Table 116. HUABIO E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. HUABIO E2 Antibody Product Portfolio Table 118. HUABIO Recent Development Table 119. G Biosciences Company Information Table 120. G Biosciences Business Overview Table 121. G Biosciences E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. G Biosciences E2 Antibody Product Portfolio Table 123. G Biosciences Recent Development Table 124. FineTest Company Information Table 125. FineTest Business Overview Table 126. FineTest E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. FineTest E2 Antibody Product Portfolio Table 128. FineTest Recent Development Table 129. Creative Diagnostics Company Information Table 130. Creative Diagnostics Business Overview Table 131. Creative Diagnostics E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Creative Diagnostics E2 Antibody Product Portfolio Table 133. Creative Diagnostics Recent Development Table 134. Creative Biolabs Company Information Table 135. Creative Biolabs Business Overview Table 136. Creative Biolabs E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Creative Biolabs E2 Antibody Product Portfolio Table 138. Creative Biolabs Recent Development Table 139. Bethyl Company Information Table 140. Bethyl Business Overview Table 141. Bethyl E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Bethyl E2 Antibody Product Portfolio Table 143. Bethyl Recent Development Table 144. Aviva Systems Biology Company Information Table 145. Aviva Systems Biology Business Overview Table 146. Aviva Systems Biology E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Aviva Systems Biology E2 Antibody Product Portfolio Table 148. Aviva Systems Biology Recent Development Table 149. Abnova Company Information Table 150. Abnova Business Overview Table 151. Abnova E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Abnova E2 Antibody Product Portfolio Table 153. Abnova Recent Development Table 154. Abcam Company Information Table 155. Abcam Business Overview Table 156. Abcam E2 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Abcam E2 Antibody Product Portfolio Table 158. Abcam Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. E2 Antibody Distributors List Table 162. E2 Antibody Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. E2 Antibody Product Image Figure 2. Global E2 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E2 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global E2 Antibody Sales (2021-2032) & (Kg) Figure 5. Global E2 Antibody Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 E2 Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polyclonal Image Figure 9. Monoclonal Image Figure 10. Global E2 Antibody Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global E2 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global E2 Antibody Sales Market Share by Type (2021-2032) Figure 13. Global E2 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global E2 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global E2 Antibody Revenue Market Share by Type (2021-2032) Figure 16. Western Blot Image Figure 17. Enzyme Linked Immunosorbent Assay Image Figure 18. Immunofluorescence Image Figure 19. Others Image Figure 20. Global E2 Antibody Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global E2 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global E2 Antibody Sales Market Share by Application (2021-2032) Figure 23. Global E2 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global E2 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global E2 Antibody Revenue Market Share by Application (2021-2032) Figure 26. North America E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America E2 Antibody Sales Market Share by Country (2021-2032) Figure 28. U.S. E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe E2 Antibody Sales Market Share by Country (2021-2032) Figure 33. Germany E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific E2 Antibody Sales Market Share by Country (2021-2032) Figure 40. China E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa E2 Antibody Sales Market Share by Country (2021-2032) Figure 48. Brazil E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile E2 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global E2 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global E2 Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America E2 Antibody Revenue (2021-2032) & (US$ Million) Figure 59. North America E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe E2 Antibody Revenue (2021-2032) & (US$ Million) Figure 61. Europe E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific E2 Antibody Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa E2 Antibody Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. E2 Antibody Value Chain Figure 67. Manufacturing Cost Structure Figure 68. E2 Antibody Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Western Blot
  • Enzyme Linked Immunosorbent Assay
  • Immunofluorescence
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • United States Biological
  • Boster Biological Technology
  • Sino Biological
  • Santa Cruz Biotechnology
  • Proteintech
  • Miltenyi Biotec
  • LSBio
  • ImmuQuest
  • HUABIO
  • G Biosciences
  • FineTest
  • Creative Diagnostics
  • Creative Biolabs
  • Bethyl
  • Aviva Systems Biology
  • Abnova
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global E2 Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global E2 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global E2 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global E2 Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global E2 Antibody Market Dynamics
  1. 2.1 E2 Antibody Industry Trends
  2. 2.2 E2 Antibody Industry Drivers
  3. 2.3 E2 Antibody Industry Opportunities and Challenges
  4. 2.4 E2 Antibody Industry Restraints
3 E2 Antibody Market by Manufacturers
  1. 3.1 Global E2 Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global E2 Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global E2 Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global E2 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global E2 Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global E2 Antibody Manufacturers, Product Type & Application
  7. 3.7 Global E2 Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global E2 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 E2 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 E2 Antibody Tier 1, Tier 2, and Tier 3
4 E2 Antibody Market by Type
  1. 4.1 E2 Antibody Type Introduction
  2. 4.1.1 Polyclonal
  3. 4.1.2 Monoclonal
  4. 4.2 Global E2 Antibody Sales by Type
  5. 4.2.1 Global E2 Antibody Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global E2 Antibody Sales by Type (2021-2032)
  7. 4.2.3 Global E2 Antibody Sales Market Share by Type (2021-2032)
  8. 4.3 Global E2 Antibody Revenue by Type
  9. 4.3.1 Global E2 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global E2 Antibody Revenue by Type (2021-2032)
  11. 4.3.3 Global E2 Antibody Revenue Market Share by Type (2021-2032)
5 E2 Antibody Market by Application
  1. 5.1 E2 Antibody Application Introduction
  2. 5.1.1 Western Blot
  3. 5.1.2 Enzyme Linked Immunosorbent Assay
  4. 5.1.3 Immunofluorescence
  5. 5.1.4 Others
  6. 5.2 Global E2 Antibody Sales by Application
  7. 5.2.1 Global E2 Antibody Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global E2 Antibody Sales by Application (2021-2032)
  9. 5.2.3 Global E2 Antibody Sales Market Share by Application (2021-2032)
  10. 5.3 Global E2 Antibody Revenue by Application
  11. 5.3.1 Global E2 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global E2 Antibody Revenue by Application (2021-2032)
  13. 5.3.3 Global E2 Antibody Revenue Market Share by Application (2021-2032)
6 Global E2 Antibody Sales by Region
  1. 6.1 Global E2 Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global E2 Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global E2 Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global E2 Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America E2 Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe E2 Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific E2 Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa E2 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa E2 Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global E2 Antibody Revenue by Region
  1. 7.1 Global E2 Antibody Revenue by Region
  2. 7.1.1 Global E2 Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global E2 Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global E2 Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global E2 Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America E2 Antibody Revenue (2021-2032)
  8. 7.2.2 North America E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe E2 Antibody Revenue (2021-2032)
  11. 7.3.2 Europe E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific E2 Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa E2 Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa E2 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific E2 Antibody Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck E2 Antibody Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 United States Biological
  14. 8.3.1 United States Biological Company Information
  15. 8.3.2 United States Biological Business Overview
  16. 8.3.3 United States Biological E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 United States Biological E2 Antibody Product Portfolio
  18. 8.3.5 United States Biological Recent Developments
  19. 8.4 Boster Biological Technology
  20. 8.4.1 Boster Biological Technology Company Information
  21. 8.4.2 Boster Biological Technology Business Overview
  22. 8.4.3 Boster Biological Technology E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boster Biological Technology E2 Antibody Product Portfolio
  24. 8.4.5 Boster Biological Technology Recent Developments
  25. 8.5 Sino Biological
  26. 8.5.1 Sino Biological Company Information
  27. 8.5.2 Sino Biological Business Overview
  28. 8.5.3 Sino Biological E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sino Biological E2 Antibody Product Portfolio
  30. 8.5.5 Sino Biological Recent Developments
  31. 8.6 Santa Cruz Biotechnology
  32. 8.6.1 Santa Cruz Biotechnology Company Information
  33. 8.6.2 Santa Cruz Biotechnology Business Overview
  34. 8.6.3 Santa Cruz Biotechnology E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Santa Cruz Biotechnology E2 Antibody Product Portfolio
  36. 8.6.5 Santa Cruz Biotechnology Recent Developments
  37. 8.7 Proteintech
  38. 8.7.1 Proteintech Company Information
  39. 8.7.2 Proteintech Business Overview
  40. 8.7.3 Proteintech E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Proteintech E2 Antibody Product Portfolio
  42. 8.7.5 Proteintech Recent Developments
  43. 8.8 Miltenyi Biotec
  44. 8.8.1 Miltenyi Biotec Company Information
  45. 8.8.2 Miltenyi Biotec Business Overview
  46. 8.8.3 Miltenyi Biotec E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Miltenyi Biotec E2 Antibody Product Portfolio
  48. 8.8.5 Miltenyi Biotec Recent Developments
  49. 8.9 LSBio
  50. 8.9.1 LSBio Company Information
  51. 8.9.2 LSBio Business Overview
  52. 8.9.3 LSBio E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LSBio E2 Antibody Product Portfolio
  54. 8.9.5 LSBio Recent Developments
  55. 8.10 ImmuQuest
  56. 8.10.1 ImmuQuest Company Information
  57. 8.10.2 ImmuQuest Business Overview
  58. 8.10.3 ImmuQuest E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ImmuQuest E2 Antibody Product Portfolio
  60. 8.10.5 ImmuQuest Recent Developments
  61. 8.11 HUABIO
  62. 8.11.1 HUABIO Company Information
  63. 8.11.2 HUABIO Business Overview
  64. 8.11.3 HUABIO E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HUABIO E2 Antibody Product Portfolio
  66. 8.11.5 HUABIO Recent Developments
  67. 8.12 G Biosciences
  68. 8.12.1 G Biosciences Company Information
  69. 8.12.2 G Biosciences Business Overview
  70. 8.12.3 G Biosciences E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 G Biosciences E2 Antibody Product Portfolio
  72. 8.12.5 G Biosciences Recent Developments
  73. 8.13 FineTest
  74. 8.13.1 FineTest Company Information
  75. 8.13.2 FineTest Business Overview
  76. 8.13.3 FineTest E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 FineTest E2 Antibody Product Portfolio
  78. 8.13.5 FineTest Recent Developments
  79. 8.14 Creative Diagnostics
  80. 8.14.1 Creative Diagnostics Company Information
  81. 8.14.2 Creative Diagnostics Business Overview
  82. 8.14.3 Creative Diagnostics E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative Diagnostics E2 Antibody Product Portfolio
  84. 8.14.5 Creative Diagnostics Recent Developments
  85. 8.15 Creative Biolabs
  86. 8.15.1 Creative Biolabs Company Information
  87. 8.15.2 Creative Biolabs Business Overview
  88. 8.15.3 Creative Biolabs E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Creative Biolabs E2 Antibody Product Portfolio
  90. 8.15.5 Creative Biolabs Recent Developments
  91. 8.16 Bethyl
  92. 8.16.1 Bethyl Company Information
  93. 8.16.2 Bethyl Business Overview
  94. 8.16.3 Bethyl E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bethyl E2 Antibody Product Portfolio
  96. 8.16.5 Bethyl Recent Developments
  97. 8.17 Aviva Systems Biology
  98. 8.17.1 Aviva Systems Biology Company Information
  99. 8.17.2 Aviva Systems Biology Business Overview
  100. 8.17.3 Aviva Systems Biology E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Aviva Systems Biology E2 Antibody Product Portfolio
  102. 8.17.5 Aviva Systems Biology Recent Developments
  103. 8.18 Abnova
  104. 8.18.1 Abnova Company Information
  105. 8.18.2 Abnova Business Overview
  106. 8.18.3 Abnova E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abnova E2 Antibody Product Portfolio
  108. 8.18.5 Abnova Recent Developments
  109. 8.19 Abcam
  110. 8.19.1 Abcam Company Information
  111. 8.19.2 Abcam Business Overview
  112. 8.19.3 Abcam E2 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Abcam E2 Antibody Product Portfolio
  114. 8.19.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 E2 Antibody Value Chain Analysis
  2. 9.1.1 E2 Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 E2 Antibody Production Mode & Process
  6. 9.2 E2 Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 E2 Antibody Distributors
  9. 9.2.3 E2 Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst